Nanox Imaging is trading 5.6% up at $0.88 ahead of its scheduled September 9 release of second-quarter 2026 results.
- The official announcement confirms the report date; investors are watching revenue, cash availability, and going-concern risks.
- The stock extended its rebound after rising 16.43% on September 4; the gain is company-specific amid healthcare-sector weakness.
- Trading remains volatile; the preview projects $5.38 million in revenue and a $0.16 loss per share, but no results have been released yet.